Adicet Bio (ACET) Interest Income - Net (2024 - 2026)
Adicet Bio (ACET) posted quarterly Interest Income - Net of -$13.7 million for Q1 2026, down 778.32% year-over-year from $2.0 million in Q1 2025, and down 1012.87% quarter-over-quarter from $1.5 million in Q4 2025.
Adicet Bio (ACET) Interest Income - Net (2024 - 2026) Analysis & Trends
Adicet Bio's Interest Income - Net history runs 3 years deep, the most recent figure standing at -$13.7 million for Q1 2026.
- In Q1 2026, Interest Income - Net fell 778.32% year-over-year to -$13.7 million; the TTM figure through Mar 2026 stood at -$29.0 million (down 21.09% YoY), while the FY2025 annual figure was -$134.8 million, down 24.11% from the prior year.
- Interest Income - Net for Q1 2026 stood at -$13.7 million, down from $1.5 million in the prior quarter.
- The five-year high for Interest Income - Net was $1.5 million in Q4 2025, with the low at -$21.6 million in Q1 2024.
- The 3-year median for Interest Income - Net is -$1.9 million (2024), against an average of -$8.3 million.
- Peak annual rise in Interest Income - Net reached 177.72% in 2025, while the deepest fall reached 1345.66% in 2025.
- Adicet Bio's Interest Income - Net stood at -$1.9 million in 2024, then jumped by 177.72% to $1.5 million in 2025, then plunged by 1012.87% to -$13.7 million in 2026.
- Business Quant data shows ACET's Interest Income - Net at -$13.7 million in Q1 2026, $1.5 million in Q4 2025, and -$3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - | 1.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.80 Mn |
| Mar 31, 2026 | -13.69 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -16.81 Mn |
| Mar 31, 2025 | -1.56 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Sep 30, 2024 | -19.31 Mn |
| Jun 30, 2024 | -1.16 Mn |
| Mar 31, 2024 | -21.62 Mn |